NASDAQ: NEUPNeuphoria Therapeutics Inc Earnings Dates, Reports, Calls
Neuphoria Therapeutics earnings were -$6.2M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest NEUP earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$6.5M, up 10.8% from last quarter. For the last reported fiscal year 2025 ending Jun 30, 2025, NEUP reported annual earnings of -$243.2k, with -97.6% growth.
NEUP earnings history
Current Revenue
$10.2M
Current Earnings
-$6.2M
Current Profit Margin
-60.5%
NEUP Return on Equity
Current Company
-53.2%
Current Industry
-21.2%
Current Market
35.1%
NEUP's Return on Equity (-53.2%)... subscribe to Premium to read more.
High Return on Equity Performance
NEUP undefined
Current Company
-36.1%
Current Industry
-8.8%
NEUP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when NEUP announces earnings.
NEUP undefined
Current Company
-44.3%
Current Industry
-3.5%
NEUP vs Biotech Stocks
Neuphoria Therapeutics Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.